Complications; Cesarean Section Completed Phase 4 Trials for Bupivacaine (DB00297)

Also known as: Complications, Cesarean Section / Cesarean Section; Complications / Cesarean Section Complications

IndicationStatusPhase
DBCOND0036878 (Complications; Cesarean Section)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03328533
Norepinephrine Versus Phenylephrine Continuous Variable Infusion in Cesarean DeliveryPrevention
NCT05664958
ESP Block for Post Cesarean AnalgesiaPrevention
NCT03182088
Norepinephrine Infusion Different Doses in Cesarean DeliveryPrevention
NCT03792906
Comparison of Two Norepinephrine Bolus Doses for Management of Post-spinal Hypotension During Cesarean DeliveryTreatment
NCT04897841
Obstetric Liposomal Bupivacaine Via Surgical Transversus Abdominis Plane Block for Post Cesarean Pain ControlTreatment
NCT04403724
Sequential and Mixture Injection of Opioids and Hyperbaric BupivacaineTreatment
NCT03234816
Vasopressor Prophylaxis After Spinal AnesthesiaPrevention
NCT03302039
Three Protocols for Phenylephrine Administration in Cesarean DeliveryPrevention
NCT05502146
Comparison of Two Different Norepinephrine Bolus Doses for Management of Spinal Anesthesia-Induced Maternal HypotensionTreatment